Patent · US Active

Neutral active soluble truncated PH20 polypeptides and uses thereof

US9284543B2 · kind B2 · utility

28Cited by

80References

22Claims

0Family size

Assignee

HALOZYME, INC. · US

Inventors

Ge Wei · San Diego, US
Krishnasamy Panneer Selvam · Poway, US
Louis H. Bookbinder · San Diego, US
Gregory I. Frost · Palm Beach, US

Key dates

Filing date	Feb 21, 2012
Grant date	Mar 15, 2016
Priority date	—
Expiry date	May 15, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.